Cevimeline hydrochloride

Pricing Availability   Qty
说明: Selective M1 agonist
别名: AF 102B,SNI 2011
化学名: cis-2-Methylspiro[1,3-oxathiolane-5,3'-quinuclidine] hydrochloride
说明书
引用文献 (1)
评论
文献 (1)

生物活性 for Cevimeline hydrochloride

Cevimeline hydrochloride is a selective M1 receptor agonist. Induces atropine-sensitive contractions of isolated guinea pig ilea and trachea preparations (EC50 values are 3.5 and 3 μM respectively). Reverses AF64A-induced cognitive impairments in vivo.

技术数据 for Cevimeline hydrochloride

分子量 235.77
公式 C10H17NOS.HCl
储存 Store at -20°C
CAS Number 107220-28-0
PubChem ID 76965955
InChI Key SKFLGMLYGHWKJG-RXUMEZLZSA-N
Smiles C[C@@H](SC3)O[C@@]13CN2CCC1CC2.C[C@H](SC6)O[C@]46CN5CCC4CC5.Cl.Cl

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for Cevimeline hydrochloride

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
water 17.68 75
DMSO 11.79 50

制备储备液 for Cevimeline hydrochloride

以下数据基于产品分子量 235.77。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
0.75 mM 5.66 mL 28.28 mL 56.55 mL
3.75 mM 1.13 mL 5.66 mL 11.31 mL
7.5 mM 0.57 mL 2.83 mL 5.66 mL
37.5 mM 0.11 mL 0.57 mL 1.13 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for Cevimeline hydrochloride

分析证书/产品说明书
选择另一批次:

参考文献 for Cevimeline hydrochloride

参考文献是支持产品生物活性的出版物。

Wanibuchi et al (1990) Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro[4.5]decane derivatives, YM796 and YM954. Eur.J.Pharmacol. 187 479 PMID: 1963596

Fisher et al (1991) (+/-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease. J.Pharmacol.Exp.Ther. 257 392 PMID: 2019998

Hargreaves et al (1992) L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors. Br.J.Pharmacol. 107 494 PMID: 1422595


If you know of a relevant reference for Cevimeline hydrochloride, please let us know.

按产品操作查看相关产品

查看全部 M1 Receptor Agonists

关键词: Cevimeline hydrochloride, Cevimeline hydrochloride supplier, AF102B, SNI2011, selective, M1, muscarinic, cholinergic, receptors, acetylcholine, Ach, agonists, AF, 102B, SNI, 2011, Receptors, 3689, Tocris Bioscience

1 篇 Cevimeline hydrochloride 的引用文献

引用文献是使用了 Tocris 产品的出版物。 Cevimeline hydrochloride 的部分引用包括:

Pasko et al (2020) Muscarinic M1 Receptors Modulate Working Memory Performance and Activity via KCNQ Potassium Channels in the Primate Prefrontal Cortex. Neuron 106 649-661.e4 PMID: 32197063


您是否知道使用了 Tocris Cevimeline hydrochloride 的优秀论文? 请告知我们.

Cevimeline hydrochloride 的评论

目前没有该产品的评论。 Be the first to review Cevimeline hydrochloride and earn rewards!

Have you used Cevimeline hydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.